A Long-Term Study of Aripiprazole in Patients With Major Depressive Disorder

Completed · Phase 3

Conditions studied: Major Depressive Disorder

In brief

This trial is a 52-week safety study to evaluate the safety of adjunctive aripiprazole in outpatients with major depressive disorder who have experienced an incomplete response to an ongoing antidepressant trial.

Key facts

Study ID

NCT00095745

Run by

Otsuka Pharmaceutical Development & Commercialization, Inc.

People needed

1002

Starts

2004-09-01

Expected to finish

2007-11-01

Last updated by the study team

2013-11-08

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Men and women, 18 years or older
• Experiencing Major Depressive Disorder with a duration of minimally 8 weeks.
• Treatment history of an inadequate response to at least one and no more than four antidepressants

Where it is running

• Local Institution — Peoria, Arizona, United States
• Local Institution — Beverly Hills, California, United States
• Local Institution — Burbank, California, United States
• Local Institution — Encino, California, United States
• Local Institution — Garden Grove, California, United States
• Local Institution — National City, California, United States
• Local Institution — Orange, California, United States
• Local Institution — Pasadena, California, United States
• Local Institution — Riverside, California, United States
• Local Institution — San Diego, California, United States
• Local Institution — Denver, Colorado, United States
• Local Institution — Farmington, Connecticut, United States
• Local Institution — Washington D.C., District of Columbia, United States
• Local Institution — Gainesville, Florida, United States
• Local Institution — Jacksonville, Florida, United States
• Local Institution — Orlando, Florida, United States
• Local Institution — Atlanta, Georgia, United States
• Local Institution — Smyrna, Georgia, United States
• Local Institution — Chicago, Illinois, United States
• Local Institution — Edwardsville, Illinois, United States
• Local Institution — Oakbrook Terrace, Illinois, United States
• Local Institution — Terre Haute, Indiana, United States
• Local Institution — Overland Park, Kansas, United States
• Local Institution — Wichita, Kansas, United States
• Local Institution — Mesa, Arizona, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.